Merus NV Sustainability Reports
Merus N.V. is a clinical-stage oncology biotechnology company that discovers and develops innovative multispecific antibody therapeutics. Its proprietary Multiclonics platforms are designed to generate therapies that engage multiple targets to enhance anti-cancer effects.
Sector: Manufacturing
Country: Netherlands
Exchange: Nasdaq
LEI: 549300W8GPUWU8QNU293
FIGI: BBG00B8LXMT4
No reports are currently available in our catalogue.